S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

ReWalk Robotics Stock Forecast, Price & News

-0.12 (-4.24 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $2.71
50-Day Range
MA: $2.99
52-Week Range
Now: $2.71
Volume3.35 million shs
Average Volume4.17 million shs
Market Capitalization$90.64 million
P/E RatioN/A
Dividend YieldN/A
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions. It offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. The company is also developing ReWalk Restore, a soft suit exoskeleton for rehabilitation of individuals suffering from a stroke. It markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
ReWalk Robotics logo


ReWalk Takes Tumble on News
February 22, 2021 |  marketwatch.com
ReWalk Robotics: Q4 Earnings Insights
February 18, 2021 |  finance.yahoo.com
ReWalk Robotics's Earnings Outlook
February 17, 2021 |  benzinga.com
Recap: ReWalk Robotics Q3 Earnings
November 10, 2020 |  finance.yahoo.com
ReWalk Robotics Reports Third Quarter 2020 Financial Results
November 10, 2020 |  finance.yahoo.com
Why ReWalk Robotics Stock Is Trading Higher Today
October 20, 2020 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolNASDAQ:RWLK
Year FoundedN/A



Sales & Book Value

Annual Sales$4.87 million
Book Value$1.48 per share


Net Income$-15,550,000.00
Net Margins-312.35%


Market Cap$90.64 million
Next Earnings Date5/27/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.45 out of 5 stars

Medical Sector

572nd out of 1,972 stocks

Surgical Appliances & Supplies Industry

13th out of 40 stocks

Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.12 (-4.24 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RWLK News and Ratings via Email

Sign-up to receive the latest news and ratings for RWLK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

ReWalk Robotics (NASDAQ:RWLK) Frequently Asked Questions

Is ReWalk Robotics a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ReWalk Robotics stock.
View analyst ratings for ReWalk Robotics
or view top-rated stocks.

What stocks does MarketBeat like better than ReWalk Robotics?

Wall Street analysts have given ReWalk Robotics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ReWalk Robotics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting ReWalk Robotics?

ReWalk Robotics saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 696,100 shares, a decrease of 40.5% from the January 14th total of 1,170,000 shares. Based on an average daily trading volume, of 2,300,000 shares, the days-to-cover ratio is presently 0.3 days.
View ReWalk Robotics' Short Interest

When is ReWalk Robotics' next earnings date?

ReWalk Robotics is scheduled to release its next quarterly earnings announcement on Thursday, May 27th 2021.
View our earnings forecast for ReWalk Robotics

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) released its quarterly earnings results on Thursday, February, 18th. The medical device company reported ($0.14) EPS for the quarter, hitting analysts' consensus estimates of ($0.14). ReWalk Robotics had a negative trailing twelve-month return on equity of 103.56% and a negative net margin of 312.35%.
View ReWalk Robotics' earnings history

How has ReWalk Robotics' stock price been impacted by Coronavirus (COVID-19)?

ReWalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RWLK stock has increased by 347.9% and is now trading at $2.71.
View which stocks have been most impacted by COVID-19

What price target have analysts set for RWLK?

1 brokerages have issued 12 month price targets for ReWalk Robotics' stock. Their forecasts range from $3.50 to $3.50. On average, they anticipate ReWalk Robotics' stock price to reach $3.50 in the next year. This suggests a possible upside of 29.2% from the stock's current price.
View analysts' price targets for ReWalk Robotics
or view top-rated stocks among Wall Street analysts.

Who are ReWalk Robotics' key executives?

ReWalk Robotics' management team includes the following people:
  • Mr. Lawrence J. Jasinski, CEO & Director (Age 64, Pay $473.59k)
  • Mr. Ori Gon, Chief Financial Officer (Age 40, Pay $262.67k)
  • Ms. Miri Pariente, VP of Operations, Regulatory & Quality (Age 44)
  • Mr. Andy Dolan, VP of Marketing & Reimbursement
  • Ms. Judy Kula, VP of Customer Service, HR & Bus. Affairs
  • Mr. Ami Kraft, Exec. Advisor to the CEO (Age 78)

Who are some of ReWalk Robotics' key competitors?

What other stocks do shareholders of ReWalk Robotics own?

What is ReWalk Robotics' stock symbol?

ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Who are ReWalk Robotics' major shareholders?

ReWalk Robotics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (4.17%), Renaissance Technologies LLC (1.24%), Virtu Financial LLC (0.48%), Koshinski Asset Management Inc. (0.02%) and Koshinski Asset Management Inc. (0.02%).
View institutional ownership trends for ReWalk Robotics

Which institutional investors are buying ReWalk Robotics stock?

RWLK stock was bought by a variety of institutional investors in the last quarter, including Armistice Capital LLC, Renaissance Technologies LLC, Virtu Financial LLC, Koshinski Asset Management Inc., and Koshinski Asset Management Inc..
View insider buying and selling activity for ReWalk Robotics
or or view top insider-buying stocks.

How do I buy shares of ReWalk Robotics?

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ReWalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $2.71.

How much money does ReWalk Robotics make?

ReWalk Robotics has a market capitalization of $90.64 million and generates $4.87 million in revenue each year. The medical device company earns $-15,550,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis.

How many employees does ReWalk Robotics have?

ReWalk Robotics employs 49 workers across the globe.

What is ReWalk Robotics' official website?

The official website for ReWalk Robotics is www.rewalk.com.

Where are ReWalk Robotics' headquarters?

ReWalk Robotics is headquartered at 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203.

How can I contact ReWalk Robotics?

ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.